Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomas of the breast.
about
PTEN function: how normal cells control it and tumour cells lose itLoss of Phosphatase and Tensin homologue deleted on chromosome 10 engages ErbB3 and insulin-like growth factor-I receptor signaling to promote antiestrogen resistance in breast cancerGenes other than BRCA1 and BRCA2 involved in breast cancer susceptibilityDeficiency of Pten accelerates mammary oncogenesis in MMTV-Wnt-1 transgenic micePhosphoinositide 3-kinase signalling in breast cancer: how big a role might it play?PTEN deficiency: a role in mammary carcinogenesis.New targets for therapy in breast cancer: mammalian target of rapamycin (mTOR) antagonistsPTEN activity could be a predictive marker of trastuzumab efficacy in the treatment of ErbB2-overexpressing breast cancerPTEN, PIK3CA, p-AKT, and p-p70S6K status: association with trastuzumab response and survival in patients with HER2-positive metastatic breast cancer.Deubiquitylase OTUD3 regulates PTEN stability and suppresses tumorigenesisPTEN: one gene, many syndromesCombined PDGFR and HDAC Inhibition Overcomes PTEN Disruption in ChordomaA Phase 1 study of UCN-01 in combination with irinotecan in patients with resistant solid tumor malignanciesThe role of epidermal growth factor receptor in chordoma pathogenesis: a potential therapeutic target.Potential value of PTEN in predicting cetuximab response in colorectal cancer: an exploratory study.Different conformations of phosphatase and tensin homolog, deleted on chromosome 10 (PTEN) protein within the nucleus and cytoplasm of neuronsGermline inactivation of PTEN and dysregulation of the phosphoinositol-3-kinase/Akt pathway cause human Lhermitte-Duclos disease in adults.Suppression of cell migration by phospholipase C-related catalytically inactive protein-dependent modulation of PI3K signallingHaploinsufficiency of the Pten tumor suppressor gene promotes prostate cancer progression.Upregulated DJ-1 promotes renal tubular EMT by suppressing cytoplasmic PTEN expression and Akt activation.Proteomic and transcriptomic profiling reveals a link between the PI3K pathway and lower estrogen-receptor (ER) levels and activity in ER+ breast cancer.Protocol for PTEN expression by immunohistochemistry in formalin-fixed paraffin-embedded human breast carcinoma.Characterization of a novel PTEN mutation in MDA-MB-453 breast carcinoma cell lineTargeted Therapy in Metastatic Breast Cancer: The HER2/neu OncogenePTEN as a prognostic and predictive marker in postoperative radiotherapy for squamous cell cancer of the head and neck.Characteristics of triple-negative breast cancerPIK3CA mutations and EGFR overexpression predict for lithium sensitivity in human breast epithelial cells.Contactin-1 reduces E-cadherin expression via activating AKT in lung cancer.PTEN overexpression suppresses proliferation and differentiation and enhances apoptosis of the mouse mammary epithelium.Acid ceramidase promotes nuclear export of PTEN through sphingosine 1-phosphate mediated Akt signaling.Can we accurately report PTEN status in advanced colorectal cancer?Lung neuroendocrine tumors: correlation of ubiquitinylation and sumoylation with nucleo-cytosolic partitioning of PTEN.Targeted therapies for breast cancer.Estrogen receptor β represses Akt signaling in breast cancer cells via downregulation of HER2/HER3 and upregulation of PTEN: implications for tamoxifen sensitivityTargeting the phosphatidylinositol 3-kinase signaling pathway in breast cancer.Diagnosis of premalignant endometrial disease.Elevated PI3K signaling drives multiple breast cancer subtypes.Epigenetic PTEN silencing in malignant melanomas without PTEN mutation.Mutation and expression analyses reveal differential subcellular compartmentalization of PTEN in endocrine pancreatic tumors compared to normal islet cellsPTEN mutational spectra, expression levels, and subcellular localization in microsatellite stable and unstable colorectal cancers.
P2860
Q24528114-89773D86-FE81-4563-9802-6463FCE97850Q24653934-CEB53D6E-C013-471F-9E0D-11A36B9855ABQ24679438-136A0951-55E4-4635-8B9B-DCC561BCDFF5Q24796025-B72E82EC-F34C-4257-9D18-3B2A4B20C8BAQ24801684-7A84F4B0-E867-48C7-BEEB-D2F98052A33FQ24801835-D7809D26-06FE-4C27-9DC4-30AADE0D9DBEQ24806542-27861B7C-3661-476E-B4C5-4F9022F97633Q27824857-E71EB08D-80A5-44FB-8813-AF815BDB7DA0Q27851582-222AB819-1231-446F-AE9A-BC84F1DD82AFQ28117749-89EF50BA-37A1-4BE0-B56A-AA356784FEBAQ28203387-FC897E48-6CF6-4E9E-AB9F-E8A1722CCD73Q30278895-AAC09BA7-20E7-4333-873D-01834286E559Q30431388-26366149-FE50-4EBC-BC71-790F63EC0F4FQ33274011-307EA6B7-08C3-4A41-959C-4B634210934FQ33359798-1DEED99A-5B6F-4771-8555-1AA4CADD8F70Q33895317-9ECFBE68-46CA-4616-B0C3-AAE268D54A96Q33905657-9F5D143E-F7F7-420D-ACA0-55E8F1E05539Q33905794-9386A15E-B32D-40D5-9EBF-42E3D148AF68Q33944717-28DAB11E-B2AD-4EE8-A6C6-9DD4C3B7731DQ33984914-3EE86A8A-BF22-46DC-A31E-F290282E5071Q34048140-F154D773-A120-4EA7-9C45-D64A52C62D24Q34066409-B61D2C2D-8FDA-4AED-9352-7F9E41B278D9Q34079578-A745218F-5EC6-45B9-B07C-BBDDD807D6C2Q34096222-A8479B30-72AA-42F3-9072-A6F3B2C46799Q34193836-83500220-45CC-4B55-A9B2-C88DFCB72353Q34479003-6C9CE7FD-E789-4CB8-84B6-7CE4AE4FC94FQ34616536-68242262-3CC2-4E96-8245-CC4036D07EC0Q34750104-3D686F02-CCD4-4F7C-B173-6F5296C80DB0Q34796595-EA8AA611-306F-4FCE-8DF7-66B2CF6C1DBEQ35009571-0AE1B4D1-9FC9-44B7-BFED-7AF5F7C2C9FCQ35101357-92924906-AED7-463D-8A85-5B3D8CE02BE8Q35151381-4112B5CA-0B2B-41A7-BDA8-85B47F629855Q35372584-8B2302C4-58AA-41B9-B328-7B4A4400C4EFQ35559028-5423739B-AC0B-4754-AE34-EADFC3199838Q35584560-3A981BC9-26EB-405C-80CC-5D306A1DC7F1Q35586140-B5BB9C3A-A88D-4EFE-BD71-86AB3C0C06CBQ35640263-6DA108E8-565F-4748-840E-0DA50C25D9EEQ35745799-4283D06E-95DF-473B-85EE-65B0888A8C6CQ35745875-69E90AF8-94D0-400E-B9D6-9DF9E23DC685Q35747653-0A30147D-DAE9-40D0-906D-0FCF1B49D993
P2860
Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomas of the breast.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Immunohistochemical evidence o ...... adenocarcinomas of the breast.
@ast
Immunohistochemical evidence o ...... adenocarcinomas of the breast.
@en
type
label
Immunohistochemical evidence o ...... adenocarcinomas of the breast.
@ast
Immunohistochemical evidence o ...... adenocarcinomas of the breast.
@en
prefLabel
Immunohistochemical evidence o ...... adenocarcinomas of the breast.
@ast
Immunohistochemical evidence o ...... adenocarcinomas of the breast.
@en
P2093
P2860
P1476
Immunohistochemical evidence o ...... adenocarcinomas of the breast.
@en
P2093
G L Mutter
L M Mulligan
P Komminoth
P2860
P304
P356
10.1016/S0002-9440(10)65227-3
P407
P577
1999-10-01T00:00:00Z